EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparison of Efficacy of Suprachoroidal Triamcinolone Acetonide Alone or in Combination With Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Prospective Comparative Study

Muhammad Tahir Ghaffar, Asad Aslam Khan iD, Mohammad Hasan Bokhari, Tahseen Mahmood Majhu, Faisal Anwar, Chaudhry Nasir Ahmed, Aalaa Saleh iD

Health Science Reports · 2026-10 · 9 (10)

DOI: 10.1002/hsr2.73257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 29.09.2026. Verfasst von Muhammad Tahir Ghaffar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology Al-Aleem Medical College Lahore Pakistan. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims This study was designed to evaluate the safety, efficacy, and durability of suprachoroidal triamcinolone acetonide, administered either alone or in combination with intravitreal bevacizumab (IVB), in the treatment of diabetic macular edema (DME).

Methods

This prospective comparative interventional study was conducted in the Ophthalmology Department at Mayo Hospital, Lahore, from May 2020 to March 2021. Sixty patients with DME were enrolled after obtaining informed consent. Baseline assessments included best‐corrected visual acuity (BCVA), intraocular pressure (IOP), a detailed fundus examination, and spectral‐domain optical coherence tomography (SD‐OCT) for measurement of central subfield thickness (CST). Participants were allocated into two groups. One group received a combination of 4 mg suprachoroidal triamcinolone acetonide and intravitreal bevacizumab, while the second group received 4 mg suprachoroidal triamcinolone acetonide alone. Patients were followed clinically and anatomically to assess treatment outcomes.

Results

Both groups demonstrated statistically significant reductions in CST from baseline ( p < 0.05). However, patients receiving combination therapy showed a greater reduction in CST and superior improvement in visual acuity compared to those receiving triamcinolone alone. At 3 months, CST and IOP decreased in both groups, with greater reductions in the combination group. The between‐group differences were significant for both CST ( p < 0.001) and IOP ( p = 0.032). No major safety concerns or treatment‐related complications were observed during the study period.

Conclusion

Suprachoroidal administration of 4 mg triamcinolone acetonide combined with intravitreal bevacizumab is more effective than triamcinolone monotherapy in reducing central subfield thickness and improving visual acuity in patients with DME. The combination approach provides superior anatomical and functional outcomes, suggesting a synergistic therapeutic effect and representing a promising treatment strategy for DME.

Schlagwörter

Stichwörter der Autor:innen

diabetic macular edemaefficacy of supra choroidal triamcinolone acetonideintravitreal anti VEGF

Autor:innen und Institutionen

  • Department of Ophthalmology Al-Aleem Medical College Lahore Pakistan.
  • Department of Ophthalmology, College of Ophthalmology and Allied Vision Sciences King Edward Medical University Lahore Pakistan.
  • Department of Ophthalmology Sharif City Medical and Dental College Lahore Pakistan.
  • Department of Medicine Lebanese University Beirut Lebanon.

ORCID-Profile: Asad Aslam Khan, Aalaa Saleh

Zitieren

APA

Ghaffar, M. T., Khan, A. A., Bokhari, M. H., Majhu, T. M., Anwar, F., Ahmed, C. N., & Saleh, A. (2026). Comparison of Efficacy of Suprachoroidal Triamcinolone Acetonide Alone or in Combination With Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Prospective Comparative Study. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.73257

Vancouver

Ghaffar MT, Khan AA, Bokhari MH, Majhu TM, Anwar F, Ahmed CN, et al. Comparison of Efficacy of Suprachoroidal Triamcinolone Acetonide Alone or in Combination With Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Prospective Comparative Study. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.73257

BibTeX
@article{Ghaffar2026,
  author = {Ghaffar, Muhammad Tahir and Khan, Asad Aslam and Bokhari, Mohammad Hasan and Majhu, Tahseen Mahmood and Anwar, Faisal and Ahmed, Chaudhry Nasir and Saleh, Aalaa},
  title = {Comparison of Efficacy of Suprachoroidal Triamcinolone Acetonide Alone or in Combination With Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Prospective Comparative Study},
  journal = {Health Science Reports},
  year = {2026},
  volume = {9},
  number = {10},
  doi = {10.1002/hsr2.73257}
}
Kostenlos starten →